Logo-bi
Review
Ailar Nakhlband, Jaleh Barar* ORCID
Bioimpacts. 2011;1(1): 7-22. doi: 10.5681/bi.2011.003
PMCID: PMC3648943     PMID: 23678403     Scopus ID: 84876715577    
PDF
XML
Cited By:
Editorial
Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2013;3(2): 49-51. doi: 10.5681/bi.2013.014
PMCID: PMC3713870     PMID: 23878787     Scopus ID: 84881521871    
PDF
XML
Cited By:
Editorial
Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2013;3(3): 105-109. doi: 10.5681/bi.2013.028
PMCID: PMC3786791     PMID: 24163801     Scopus ID: 84887341756    
PDF
XML
Cited By:
Review
Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2013;3(4): 149-162. doi: 10.5681/bi.2013.036
PMCID: PMC3892734     PMID: 24455478     Scopus ID: 84893354269    
Review
Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2014;4(1): 3-14. doi: 10.5681/bi.2014.011
PMCID: PMC4005281     PMID: 24790893     Scopus ID: 84898640100    
PDF
XML
Cited By:
Original Research
Mohammad Johari-Ahar, Jaleh Barar* ORCID, Pari Karami, Davoud Asgari, Soodabeh Davaran, Mohammad-Reza Rashidi*
Bioimpacts. 2018;8(4): 263-270. doi: 10.15171/bi.2018.29
PMCID: PMC6209831     PMID: 30397581     Scopus ID: 85056094508    
Original Research
Yalda RahbarSaadat, Nazli Saeidi, Sepideh Zununi Vahed, Abolfazl Barzegari*, Jaleh Barar ORCID
Bioimpacts. 2015;5(1): 25-28. doi: 10.15171/bi.2015.01
PMCID: PMC4401164     PMID: 25901294     Scopus ID: 84924904679    
Original Research
Morteza Eskandani, Elmira Dadizadeh, Hamed Hamishehkar, Hossein Nazemiyeh*, Jaleh Barar* ORCID
Bioimpacts. 2014;4(4): 191-198. doi: 10.15171/bi.2014.019
PMCID: PMC4298710     PMID: 25671175     Scopus ID: 84920984152    
PDF
XML
Cited By:
Review
Yadollah Omidi ORCID, Jaleh Barar* ORCID
Bioimpacts. 2014;4(2): 55-67. doi: 10.5681/bi.2014.021
PMCID: PMC4097973     PMID: 25035848     Scopus ID: 84905435584    
Original Research
Hamid Reza Heidari, Mojgan Bandehpour, Hossein Vahidi, Jaleh Barar ORCID, Bahram Kazemi*, Hossein Naderi-Manesh*
Bioimpacts. 2014;4(3): 123-132. doi: 10.15171/bi.2014.005
PMCID: PMC4204037     PMID: 25337465     Scopus ID: 84908156099    
PDF
XML
Cited By:
Review
Omid Mashinchian, Mohammad Johari-Ahar, Behnaz Ghaemi, Mohammad Rashidi, Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2014;4(3): 149-166. doi: 10.15171/bi.2014.008
PMCID: PMC4204040     PMID: 25337468     Scopus ID: 84908221773    
Review
Mehdi Saberian-Borujeni, Mohammad Johari-Ahar, Hossein Hamzeiy, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2014;4(4): 205-215. doi: 10.15171/bi.2014.015
PMCID: PMC4298712     PMID: 25671177     Scopus ID: 84920996057    
PDF
XML
Cited By:
Editorial
Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(2): 65-69. doi: 10.15171/bi.2015.18
PMCID: PMC4492186     PMID: 26191499     Scopus ID: 84930410369    
PDF
XML
Cited By:
Editorial
Jaleh Barar* ORCID
Bioimpacts. 2015;5(3): 113-115. doi: 10.15171/bi.2015.23
PMCID: PMC4597157     PMID: 26457247     Scopus ID: 84944413654    
PDF
XML
Cited By:
Editorial
Marzieh Fathi, Jaleh Barar ORCID, Ayuob Aghanejad, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(4): 159-164. doi: 10.15171/bi.2015.31
PMCID: PMC4769784     PMID: 26929918     Scopus ID: 84958155033    
Review
Saeideh Same, Ayuob Aghanejad, Sattar Akbari Nakhjavani, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2016;6(3): 169-181. doi: 10.15171/bi.2016.23
PMCID: PMC5108989     PMID: 27853680     Scopus ID: 85004064338    
Original Research
Mina Sattari, Marziyeh Fathi, Mansour Daei, Hamid Erfan-Niya*, Jaleh Barar ORCID, Ali Akbar Entezami
Bioimpacts. 2017;7(3): 167-175. doi: 10.15171/bi.2017.20
PMCID: PMC5684508     PMID: 29159144     Scopus ID: 85032034810    
Original Research
Masoud Asadi-Khiavi, Hossein Hamzeiy*, Sajjad Khani, Ailar Nakhlband, Jaleh Barar* ORCID
Bioimpacts. 2011;1(2): 113-119. doi: 10.5681/bi.2011.015
PMCID: PMC3648953     PMID: 23678415     Scopus ID: 84874688024    
PDF
XML
Cited By:
Methodology
Sara Samadi Shams, Sepideh Zununi Vahed, Farzaneh Soltanzad, Vala Kafil, Abolfazl Barzegari, Sina Atashpaz, Jaleh Barar* ORCID
Bioimpacts. 2011;1(3): 183-187. doi: 10.5681/bi.2011.025
PMCID: PMC3648961     PMID: 23678425     Scopus ID: 84876736856    
PDF
XML
Cited By:
Editorial
Jaleh Barar* ORCID
Bioimpacts. 2012;2(1): 1-3. doi: 10.5681/bi.2012.001
PMCID: PMC3648920     PMID: 23678436     Scopus ID: 84876816540    
PDF
XML
Cited By:
Review
Yadollah Omidi* ORCID, Jaleh Barar ORCID
Bioimpacts. 2012;2(1): 5-22. doi: 10.5681/bi.2012.002
PMCID: PMC3648919     PMID: 23678437     Scopus ID: 84876731279    
PDF
XML
Cited By:
Correction
Ailar Nakhlband, Jaleh Barar* ORCID
Bioimpacts. 2012;2(1): 69. doi: 10.5681/bi.2012.009
PMCID: PMC3648917     PMID: 37535851     Scopus ID: 84876815665    
PDF
XML
Cited By:
Original Research
Mohsen Ebrahimi, Mohammad Johari-Ahar, Hossein Hamzeiy*, Jaleh Barar ORCID, Omid Mashinchian, Yadollah Omidi* ORCID
Bioimpacts. 2012;2(2): 91-95. doi: 10.5681/bi.2012.013
PMCID: PMC3648926     PMID: 23678446     Scopus ID: 84865375417    
PDF
XML
Cited By:
Review
Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2012;2(3): 127-143. doi: 10.5681/bi.2012.025
PMCID: PMC3648930     PMID: 23678451     Scopus ID: 84874512835    
PDF
XML
Cited By:
Review
Jaleh Barar ORCID, Ayuob Aghanejad, Marziyeh Fathi, Yadollah Omidi* ORCID
Bioimpacts. 2016;6(1): 49-67. doi: 10.15171/bi.2016.07
PMCID: PMC4916551     PMID: 27340624     Scopus ID: 84977080654    
Review
Marziyeh Fathi, Jaleh Barar* ORCID
Bioimpacts. 2017;7(1): 49-57. doi: 10.15171/bi.2017.07
PMCID: PMC5439389     PMID: 28546953     Scopus ID: 85019106716    
Review
Jaleh Barar ORCID, Mohammad A. Rafi, Mohammad M. Pourseif, Yadollah Omidi* ORCID
Bioimpacts. 2016;6(4): 225-248. doi: 10.15171/bi.2016.30
PMCID: PMC5326671     PMID: 28265539     Scopus ID: 85013096202    
Review
Mohammad Reza Asgharzadeh, Jaleh Barar ORCID, Mohammad M. Pourseif, Morteza Eskandani, Mojtaba Jafari Niya, Mohammad Reza Mashayekhi, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(2): 115-133. doi: 10.15171/bi.2017.15
PMCID: PMC5524986     PMID: 28752076     Scopus ID: 85027460324    
Original Research
Jaber Dehghani, Ali Movafeghi*, Abolfazl Barzegari, Jaleh Barar* ORCID
Bioimpacts. 2017;7(4): 247-254. doi: 10.15171/bi.2017.29
PMCID: PMC5801536     PMID: 29435432     Scopus ID: 85040972974    
Review
Marziyeh Fathi, Parham Sahandi Zangabad, Sima Majidi, Jaleh Barar, Hamid Erfan-Niya, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(4): 269-277. doi: 10.15171/bi.2017.32
PMCID: PMC5801539     PMID: 29435435     Scopus ID: 85041008382    
Review
Ailar Nakhlband, Morteza Eskandani, Yadollah Omidi ORCID, Nazli Saeedi, Samad Ghafari, Jaleh Barar* ORCID, Alireza Garjani*
Bioimpacts. 2018;8(1): 59-75. doi: 10.15171/bi.2018.08
PMCID: PMC5915710     PMID: 29713603     Scopus ID: 85044298919    
Original Research
Ayuob Aghanejad, Hiwa Babamiri, Khosro Adibkia, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2018;8(2): 117-127. doi: 10.15171/bi.2018.14
PMCID: PMC6026525     PMID: 29977833     Scopus ID: 85048082430    
Editorial
Azam Safary ORCID, Mostafa Akbarzadeh Khiavi ORCID, Rahimeh Mousavi, Jaleh Barar ORCID, Mohammad A Rafi*
Bioimpacts. 2018;8(3): 153-157. doi: 10.15171/bi.2018.17
PMCID: PMC6128977     PMID: 30211074     Scopus ID: 85050655722    
Editorial
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(2): 67-70. doi: 10.15171/bi.2019.09
PMCID: PMC6637218     PMID: 31334037     Scopus ID: 85067455587    
Aptamers (Aps) are short single-strand nucleic acids, which can be used as the therapeutic and targeting agent in advanced drug delivery systems. Conjugation of Aps with other entities (siRNA, toxins, drugs, DNAzyme/Ribozymes) provides advanced multifunctional nanosystems for cancer therapy.
Original Research
Mohammad Reza Asgharzadeh, Mohammad M. Pourseif, Jaleh Barar ORCID, Morteza Eskandani, Mojtaba Jafari Niya, Mohammad Reza Mashayekhi, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(3): 145-159. doi: 10.15171/bi.2019.19
PMCID: PMC6726749     PMID: 31508330     Scopus ID: 85071154393    
Increased expression of TSGA10 associated with the reduced metastasis in the MDA-MB-231 cells. TSGA10 showed interaction with HIF-1α with high affinity. TSGA10 expression is altered under the hypoxia, indicating its potential as a bio-target for cancer therapy.
Editorial
Nastran Hashemzadeh, Khosro Adibkia ORCID, Jaleh Barar* ORCID
Bioimpacts. 2019;9(1): 1-3. doi: 10.15171/bi.2019.01
PMCID: PMC6378097     PMID: 30788254     Scopus ID: 85060480524    
Original Research
Elaheh Dalir Abdolahinia, Behzad Jafari, Sepideh Parvizpour, Jaleh Barar ORCID, Samad Nadri*, Yadollah Omidi* ORCID
BioImpacts. 2021;11(2): 111-117. doi: 10.34172/bi.2021.18
PMCID: PMC8022235     PMID: 33842281     Scopus ID: 85106569770    
Based on in vitro and in silico findings, MC is suggested as an important ECMmimicking entity that can support the semi-solid medium and promote the formation of the uniform spheroid in the 3D culture.
Original Research
Hadi Maleki-Kakelar ORCID, Jaber Dehghani, Abolfazl Barzegari, Jaleh Barar ORCID, Masoud Shirmohamadi, Javid Sadeghi, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(2): 65-72. doi: 10.34172/bi.2020.09
PMCID: PMC7186545     PMID: 32363150     Scopus ID: 85088607061    
Based on in vitro experiments, the anti-cancer effect of the locally isolated L. plantarum was validated through some signaling pathways, including PTEN, Bax, TLR4, and AKT genes.
Original Research
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Jaleh Barar ORCID, Hamed Farzi-Khajeh, Abolfazl Barzegari, Rahimeh Mousavi, Mohammad Hossein Somi* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(1): 27-36. doi: 10.15171/bi.2020.04
PMCID: PMC6977588     PMID: 31988854     Scopus ID: 85078959970    
The current study introduces an efficient ROS-responsive enzyme-based nanobiosystem and its biological impact in colon cancer therapy. Based on physicochemical properties, AuNPs-PEG-RNase A effectively induced apoptosis in SW-480 colon cancer cells and resulted in a significant reduction in cancer cell viability.
Editorial
Marziyeh Fathi ORCID, Azam Safary ORCID, Jaleh Barar* ORCID
Bioimpacts. 2020;10(1): 1-4. doi: 10.15171/bi.2020.01
PMCID: PMC6977590     PMID: 31988850     Scopus ID: 85078980716    
Jaleh Barar (PharmD, PhD) is Professor of Drug Delivery and Targeting. She currently is the chair of the department of Pharmaceutics at the Faculty of Pharmacy, Tabriz university of Medical Sciences. Professor Barar’s research is focused on various aspects of the pharmaceutical cell biology with the particular emphasis on the development of novel drug delivery and targeting strategies to combat cancer.
Perspective
Siamak Alizadeh ORCID, Abolghasem Esmaeili, Jaleh Barar ORCID, Yadollah Omidi* ORCID
BioImpacts. 2022;12(4): 295-299. doi: 10.34172/bi.2021.22179
PMCID: PMC9376163     PMID: 35975208     Scopus ID: 85137389032    
Optogenetics approaches can provide us with outstanding tool to extend our understanding of how cells perceive, respond, and behave in meeting with complex signals, particularly in terms of cancer evasion from the anticancer immune system functions.
Editorial COVID-19
Jaleh Barar* ORCID
Bioimpacts. 2020;10(3): 137-138. doi: 10.34172/bi.2020.16
PMCID: PMC7416010     PMID: 32793434     Scopus ID: 85089709760    
The vast knowledge about the pathways that regulate the virus entry and molecular signaling of the pathogenesis of coronavirus are the key factor for the development of de novo nanoscaled diagnostic/therapeutic strategies.
Original Research
Solmaz Zakhireh ORCID, Jaleh Barar* ORCID, Younes Beygi-Khosrowshahi, Abolfazl Barzegari, Yadollah Omidi, Khosro Adibkia* ORCID
BioImpacts. 2022;12(3): 183-193. doi: 10.34172/bi.2021.24
PMCID: PMC9124872     PMID: 35677670     Scopus ID: 85132071807    
The pollen grain of Pistacia vera L. is proposed as a scaffolding building block with the encapsulation capability of bioactive compounds. A modified simple method was developed to create nonallergic hollow pollen grains (HPGs).
Editorial
Roghaiyeh Ilghami ORCID, Hafez Mohammadhasanzadeh ORCID, Jaleh Barar ORCID, Mohammad A. Rafi* ORCID
Bioimpacts. 2020;10(4): 207-208. doi: 10.34172/bi.2020.26
PMCID: PMC7502912     PMID: 32983935     Scopus ID: 85092069314    
Mohammad Rafi received his PhD in Animal Biology from the University of Montpellier, France, in 1970. Though he has worked on several lysosomal storage diseases, his main research interest is gene therapy of neurodegenerative disorders using animal models of globoid cell leukodystrophy (Krabbe disease). With successful AAVrh10-mediated treatment of murine and canine models, his research is moving towards the treatment trials of human patients.
Original Research
Efthymia-Iliana Matthaiou ORCID, Yi Guo, Jaleh Barar ORCID, Raphael Sandaltzopoulos, Lana E. Kandalaft, Chunsheng Li*, George Coukos, Yadollah Omidi* ORCID
Bioimpacts. 2022;12(1): 65-86. doi: 10.34172/bi.2021.23511
PMCID: PMC8783079     PMID: 35087718     Scopus ID: 85127176631    
Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) functionalized with polyethylene glycol (PEG)and anti-TEM1 antibody fragment (78Fc) and loaded with necrosis-inducing agent shikonin (SHK)(78Fc-PLGA-SHK NPs) is a highly effective immunostimulating nanomedicine against theTEM1-expressing cells for targeted therapy of solid tumors.
Original Research
Mohammad Samiei ORCID, Elaheh Dalir Abdollahinia ORCID, Nazanin Amiryaghoubi ORCID, Marziyeh Fathi* ORCID, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2023;13(1): 63-72. doi: 10.34172/bi.2022.23904
PMCID: PMC9923811     PMID: 36816999     Scopus ID: 85146923274    
Injectable thermosensitive hydrogel (PNIPAAm-g-CS copolymer/gelatin hybrid hydrogel) can be used for osteogenic differentiation of human dental pulp stem cells (hDPSCs).
Editorial
Yalda Rahbar Saadat ORCID, Jaleh Barar* ORCID
BioImpacts. 2022;12(2): 87-88. doi: 10.34172/bi.2022.24253
PMCID: PMC8905586     PMID: 35411296     Scopus ID: 85127210127    
Jaleh Barar (PharmD, Ph.D.) is a Full Professor at the Faculty of Pharmacy, Tabriz University of Medical Sciences. Professor Barar is working on various aspects of pharmaceutical cell biology with particular emphasis on the development of novel drug delivery/targeting systems. Dr Barar is listed among top 1% of world scientists based on ESI ranking system.
Original Article
Mitra Torabi ORCID, Ayuob Aghanejad*, Pouria Savadi ORCID, Abolfazl Barzegari, Yadollah Omidi ORCID, Jaleh Barar* ORCID
Bioimpacts. 2023;13(3): 255-267. doi: 10.34172/bi.2023.25298
PMCID: PMC10329750     PMID: 37431477     Scopus ID: 85158830047    
Owing to their unique advantages, mesoporous silica nanoparticles (MSNPs) have attracted much attention for drug delivery and targeting. In the current study, MSNPs were fabricated, PEGylated, loaded with sunitinib, and conjugated with mucin-16 aptamer to target CA125 on ovarian cancer cells.
Editorial
Azam Safary ORCID, Mostafa Akbarzadeh-Khiavi ORCID, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2023;13(4): 269-273. doi: 10.34172/bi.2023.27494
PMCID: PMC10460773     PMID: 37645029     Scopus ID: 85168085723    
Professor Yadollah Omidi has a Ph.D. degree in Pharmaceutical Sciences (2003, Cardiff University, UK). He is currently working as a full professorat Nova Southeastern University College of Pharmacy, Florida. He has consecutively been listedamong top 1% highly cited scientists worldwide by WoS-ESI.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge